Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Carcinoma, Non Small Cell Lung

In brief

To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.

Key facts

Study ID

NCT00191256

Run by

Eli Lilly and Company

People needed

77

Starts

2001-06-01

Expected to finish

2006-07-01

Last updated by the study team

2007-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically confirmed non small cell lung cancer
• No prior chemotherapy or radiation for non small cell lung cancer
• No prior malignancy

You may not qualify if…

• Pregnancy or breastfeeding
• Serious concomitant disorders

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.